Dr. Edgar V. Lerma, MD

Areas of expertise and specialization

Faculty Titles & Positions

• Clinical Professor of Medicine University of Illinois at Chicago 2012 - Present
• Educational Coordinator, Section of Nephrology Advocate Christ Medical Center 2008 - Present

Professional Memberships

• American College of Physicians  
• American Society of Nephrology  
• National Kidney Foundation  
• American Society of Diagnostic and Interventional Nephrology  
• American Heart Association  
• National Lipid Association  
• International Society of Nephrology  

Internships

• Internal Medicine, Mercy Hospital and Medical Center/ University of Illinois at Chicago, Chicago, IL

Fellowships

• Nephrology and Hypertension, Northwestern University. Chicago, IL

Articles and Publications

• 1.Recent Developments in the Evaluation and Management of Cardiorenal Syndrome: A Comprehensive Review.Kim JA, Wu L, Rodriguez M, Lentine KL, Virk HUH, Hachem KE, Lerma EV, Kiernan MS, Rangaswami J, Krittanawong C.Curr Probl Cardiol. 2023 Mar;48(3):101509. doi: 10.1016/j.cpcardiol.2022.101509. Epub 2022 Nov 17.PMID: 36402213 Review.2.Aortic Stenosis and Aortic Valve Replacement Among Patients with Chronic Kidney Disease: A Narrative Review.Rivera FB, Cu MVV, Cua SJ, De Luna DV, Lerma EV, McCullough PA, Kazory A, Collado FMS.Cardiorenal Med. 2023 Feb 22. doi: 10.1159/000529543. Online ahead of print.PMID: 36812906 Review.3.Transcatheter Aortic Valve Replacement (TAVR)-associated Acute Kidney Injury: An Update.Rivera FB, Al-Abcha A, Ansay MFM, Magalong JVU, Tang VAS, Ona HM, Miralles KA, Sausa R, Uy RAF, Lerma EV, Collado FMS, McCullough PA, Volgman AS.Cardiorenal Med. 2023 Feb 17. doi: 10.1159/000529729. Online ahead of print.PMID: 36801854 Review.4.Empagliflozin in Adults with Chronic Kidney Disease (CKD): Current Evidence and Place in Therapy.Colbert GB, Madariaga HM, Gaddy A, Elrggal ME, Lerma EV.Ther Clin Risk Manag. 2023 Feb 2;19:133-142. doi: 10.2147/TCRM.S398163. eCollection 2023.PMID: 36756278 Free PMC article. Review.5.Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Perl J, Brown EA, Chan CT, Couchoud C, Davies SJ, Kazancioglu R, Klarenbach S, Liew A, Weiner DE, Cheung M, Jadoul M, Winkelmayer WC, Wilkie M; for Conference Participants.Kidney Int. 2023 Jan 31:S0085-2538(23)00051-0. doi: 10.1016/j.kint.2023.01.006. Online ahead of print.PMID: 367316116.The presentation, etiologies, pathophysiology, and treatment of pulmonary renal syndrome: A review of the literature.Martin K, Deleveaux S, Cunningham M, Ramaswamy K, Thomas B, Lerma E, Madariaga H.Dis Mon. 2022 Dec;68(12):101465. doi: 10.1016/j.disamonth.2022.101465. Epub 2022 Aug 23.PMID: 36008166 Review.7.Foreword.Leikin JB, Lerma EV.Dis Mon. 2022 Dec;68(12):101464. doi: 10.1016/j.disamonth.2022.101464. Epub 2022 Aug 11.PMID: 35963788 No abstract available.8.Donor derived infections in kidney transplant.Ramaswamy K, Madariaga HM, Zheng L, Thomas B, Lerma EV.Dis Mon. 2022 Dec;68(12):101330. doi: 10.1016/j.disamonth.2022.101330. Epub 2022 Feb 24.PMID: 35221018 No abstract available.9.Global challenges with providing vascular access care during COVID era.Ramani K, Vachharajani TJ, Lerma E, Agarwal AK.J Vasc Access. 2022 Oct 6:11297298221106853. doi: 10.1177/11297298221106853. Online ahead of print.PMID: 36203353 Free PMC article.10.Diagnosis 101: diabetic kidney disease.Lerma EV.Clin Kidney J. 2022 Jun 28;15(10):1797-1799. doi: 10.1093/ckj/sfac163. eCollection 2022 Oct.PMID: 36158143 Free PMC article.11.The Case for a Kidney Emoji.Seethapathy H, Beach J, Gillcrist M, Conway PT, Teakell J, Lee J, Vlasschaert C, He S, Lerma E.Am J Kidney Dis. 2022 Aug;80(2):155-157. doi: 10.1053/j.ajkd.2022.03.012. Epub 2022 May 2.PMID: 35513182 No abstract available.12.Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia.Colbert G, Sannapaneni S, Lerma EV.Drug Healthc Patient Saf. 2022 Jul 14;14:87-96. doi: 10.2147/DHPS.S338579. eCollection 2022.PMID: 35860695 Free PMC article. Review.13.Diabetic ketoacidosis.Calimag APP, Chlebek S, Lerma EV, Chaiban JT.Dis Mon. 2022 May 13:101418. doi: 10.1016/j.disamonth.2022.101418. Online ahead of print.PMID: 3557761714.Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis.van Gelder T, Lerma E, Engelke K, Huizinga RB.Expert Rev Clin Pharmacol. 2022 May;15(5):515-529. doi: 10.1080/17512433.2022.2092470. Epub 2022 Jul 11.PMID: 35763288 Review.15.Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes.Lerma EV, Wilson DJ.Expert Rev Clin Pharmacol. 2022 May;15(5):501-513. doi: 10.1080/17512433.2022.2094770. Epub 2022 Jul 3.PMID: 35762406 Review.16.Gender interactions on Twitter and medical education: how is nephrology doing?Madariaga HM, Sieberg CB, Vela X, Kwon K, Lerma EV, Desai T.Nephrol Dial Transplant. 2022 Apr 25;37(5):923-927. doi: 10.1093/ndt/gfab058.PMID: 3367756617.Effectiveness of nonsteroidal mineralocorticoid receptor antagonists in patients with diabetic kidney disease.Lerma E, White WB, Bakris G.Postgrad Med. 2022 Apr 20:1-10. doi: 10.1080/00325481.2022.2060598. Online ahead of print.PMID: 35392754 Review.18.Challenges and Opportunities of a Virtual Nephrology Meeting: The ISN World Congress of Nephrology 2021.Claure-Del Granado R, Anandh U, Lerma E, Conjeevaram A, Arce-Amar F, Dos Santos ACS Jr, Basu G, Bek S, Dhakal AK, Gawad MA, AkL A, Turgut D, Karam S, Bajpai D, Pecoits-Filho R, Parikh N.Kidney Int Rep. 2022 Feb;7(2):133-137. doi: 10.1016/j.ekir.2021.11.039. Epub 2021 Dec 8.PMID: 35036661 Free PMC article. No abstract available.19.Blood Pressure Management in the Patient with Chronic Kidney Disease.Muntner P, Cushman WC, Lerma EV.Clin J Am Soc Nephrol. 2022 Feb;17(2):308-310. doi: 10.2215/CJN.13040921. Epub 2022 Jan 5.PMID: 34987024 Free PMC article. No abstract available.20.Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities.Vijay K, Neuen BL, Lerma EV.Cardiorenal Med. 2022;12(1):1-10. doi: 10.1159/000520909. Epub 2021 Nov 19.PMID: 34802000 Review.21.Optimizing Renin-Angiotensin System Inhibitor Use in CKD.Chang TI, Lerma EV.Clin J Am Soc Nephrol. 2022 Jan;17(1):131-133. doi: 10.2215/CJN.12950921. Epub 2021 Nov 17.PMID: 34789477 Free PMC article. No abstract available.22.Update and review of contrast-associated acute kidney injury.Colbert GB, Patel TK, Gaddy A, Lerma E.Dis Mon. 2022 Jan;68(1):101272. doi: 10.1016/j.disamonth.2021.101272. Epub 2021 Jul 22.PMID: 3430486823.A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19).May RM, Cassol C, Hannoudi A, Larsen CP, Lerma EV, Haun RS, Braga JR, Hassen SI, Wilson J, VanBeek C, Vankalakunti M, Barnum L, Walker PD, Bourne TD, Messias NC, Ambruzs JM, Boils CL, Sharma SS, Cossey LN, Baxi PV, Palmer M, Zuckerman JE, Walavalkar V, Urisman A, Gallan AJ, Al-Rabadi LF, Rodby R, Luyckx V, Espino G, Santhana-Krishnan S, Alper B, Lam SG, Hannoudi GN, Matthew D, Belz M, Singer G, Kunaparaju S, Price D, Chawla S, Rondla C, Abdalla MA, Britton ML, Paul S, Ranjit U, Bichu P, Williamson SR, Sharma Y, Gaspert A, Grosse P, Meyer I, Vasudev B, El Kassem M, Velez JCQ, Caza TN.Kidney Int. 2021 Dec;100(6):1303-1315. doi: 10.1016/j.kint.2021.07.015. Epub 2021 Aug 3.PMID: 34352311 Free PMC article.24.Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC, Stevens PE; Conference Participants.Kidney Int. 2021 Sep;100(3):516-526. doi: 10.1016/j.kint.2021.06.028. Epub 2021 Jul 9.PMID: 3425245025.Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.Carr EJ, Kronbichler A, Graham-Brown M, Abra G, Argyropoulos C, Harper L, Lerma EV, Suri RS, Topf J, Willicombe M, Hiremath S.Kidney Int Rep. 2021 Sep;6(9):2292-2304. doi: 10.1016/j.ekir.2021.06.027. Epub 2021 Jul 6.PMID: 34250319 Free PMC article.26.Sodium zirconium cyclosilicate for the management of chronic hyperkalemia in kidney disease, a novel agent.Rastogi A, Hanna RM, Mkrttchyan A, Khalid M, Yaqoob S, Shaffer K, Dhawan P, Nobakht N, Kamgar M, Goshtaseb R, Sarmosyan K, Gnarini M, Wassef O, Lerma E.Expert Rev Clin Pharmacol. 2021 Sep;14(9):1055-1064. doi: 10.1080/17512433.2021.1932460. Epub 2021 Jul 6.PMID: 34227913 Review.27.PICC line management among patients with chronic kidney disease.Oza-Gajera BP, Davis JA, Farrington C, Lerma EV, Moossavi S, Sheta MA, Dwyer A, Almehmi A.J Vasc Access. 2021 Jul 3:11297298211025897. doi: 10.1177/11297298211025897. Online ahead of print.PMID: 3421870828.Lessons learnt and future directions in managing dialysis access during the COVID 19 pandemic: Patient and provider experience in the United States.Agarwal AK, Sequeira A, Oza-Gajera BP, Ramani K, Packer J, Litchfield T, Nations ML, Lerma EV.J Vasc Access. 2021 Jun 24:11297298211027014. doi: 10.1177/11297298211027014. Online ahead of print.PMID: 3416227629.Update and review of renal artery stenosis.Colbert GB, Abra G, Lerma EV.Dis Mon. 2021 Jun;67(6):101118. doi: 10.1016/j.disamonth.2020.101118. Epub 2020 Dec 7.PMID: 33303204 Review. No abstract available.30.Erratum to: Sodium Zirconium Cyclosilicate Increases Serum Bicarbonate Concentrations Among Patients with Hyperkalaemia: Exploratory Analyses from Three Randomized, Multi-Dose, Placebo-Controlled Trials.Roger SD, Spinowitz BS, Lerma EV, Fishbane S, Ash SR, Martins JG, Quinn CM, Packham DK.Nephrol Dial Transplant. 2021 May 27;36(6):1139. doi: 10.1093/ndt/gfaa305.PMID: 33263750 Free PMC article. No abstract available.31.Sodium zirconium cyclosilicate increases serum bicarbonate concentrations among patients with hyperkalaemia: exploratory analyses from three randomized, multi-dose, placebo-controlled trials.Roger SD, Spinowitz BS, Lerma EV, Fishbane S, Ash SR, Martins JG, Quinn CM, Packham DK.Nephrol Dial Transplant. 2021 Apr 26;36(5):871-883. doi: 10.1093/ndt/gfaa158.PMID: 32588050 Free PMC article.32.Anemia management for home dialysis including the new US public policy initiative.Rastogi A, Lerma EV.Kidney Int Suppl (2011). 2021 Apr;11(1):59-69. doi: 10.1016/j.kisu.2020.12.005. Epub 2021 Mar 18.PMID: 33777496 Free PMC article.33.Clinical Management of Hyperkalemia.Palmer BF, Carrero JJ, Clegg DJ, Colbert GB, Emmett M, Fishbane S, Hain DJ, Lerma E, Onuigbo M, Rastogi A, Roger SD, Spinowitz BS, Weir MR.Mayo Clin Proc. 2021 Mar;96(3):744-762. doi: 10.1016/j.mayocp.2020.06.014. Epub 2020 Nov 5.PMID: 33160639 Review.34.Hepatitis C and Treatment in Patients with Chronic Kidney Disease.Jalota A, Lindner BK, Thomas B, Lerma EV.Dis Mon. 2021 Feb;67(2):101017. doi: 10.1016/j.disamonth.2020.101017. Epub 2020 Jun 16.PMID: 32553421 Review.35.The Role of Serum Chloride in Acute and Chronic Heart Failure: A Narrative Review.Rivera FB, Alfonso P, Golbin JM, Lo K, Lerma E, Volgman AS, Kazory A.Cardiorenal Med. 2021;11(2):87-98. doi: 10.1159/000515604. Epub 2021 Apr 19.PMID: 33873189 Review.36.Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection.McCullough PA, Kelly RJ, Ruocco G, Lerma E, Tumlin J, Wheelan KR, Katz N, Lepor NE, Vijay K, Carter H, Singh B, McCullough SP, Bhambi BK, Palazzuoli A, De Ferrari GM, Milligan GP, Safder T, Tecson KM, Wang DD, McKinnon JE, O'Neill WW, Zervos M, Risch HA.Am J Med. 2021 Jan;134(1):16-22. doi: 10.1016/j.amjmed.2020.07.003. Epub 2020 Aug 7.PMID: 32771461 Free PMC article. Review.37.Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.Roger SD, Lavin PT, Lerma EV, McCullough PA, Butler J, Spinowitz BS, von Haehling S, Kosiborod M, Zhao J, Fishbane S, Packham DK.Nephrol Dial Transplant. 2021 Jan 1;36(1):137-150. doi: 10.1093/ndt/gfz285.PMID: 32030422 Free PMC article. Clinical Trial.38.Utility of telemedicine in the COVID-19 era.Colbert GB, Venegas-Vera AV, Lerma EV.Rev Cardiovasc Med. 2020 Dec 30;21(4):583-587. doi: 10.31083/j.rcm.2020.04.188.PMID: 3338800339.Positive and negative impact of social media in the COVID-19 era.Venegas-Vera AV, Colbert GB, Lerma EV.Rev Cardiovasc Med. 2020 Dec 30;21(4):561-564. doi: 10.31083/j.rcm.2020.04.195.PMID: 33388000 Review.40.A Picture Is Worth a Thousand Views: A Triple Crossover Trial of Visual Abstracts to Examine Their Impact on Research Dissemination.Oska S, Lerma E, Topf J.J Med Internet Res. 2020 Dec 4;22(12):e22327. doi: 10.2196/22327.PMID: 33275112 Free PMC article.41.Anticoagulation-related nephropathy for the internist: a concise review.Mezue K, Ram P, Egbuche O, Menezes RG, Lerma E, Rangaswami J.Am J Cardiovasc Dis. 2020 Oct 15;10(4):301-305. eCollection 2020.PMID: 33224577 Free PMC article. Review.42.Social Media Coverage of the International Society of Nephrology World Congress of Nephrology 2019: Exploring Novel Strategies.Anandh U, Basu G, Bajpai D, Shingada AK, Lerma EV, Bek SG, Lopez-Almaraz E, Claure-Del Granado R, Arce-Amare F, Dheerendra P, Conjeevaram A; @ISNEducation Social Media Team of the World Congress of Nephrology 2019.Kidney Int Rep. 2020 Aug 13;5(10):1615-1619. doi: 10.1016/j.ekir.2020.07.038. eCollection 2020 Oct.PMID: 33102953 Free PMC article. No abstract available.43.COVID-19 Extrapulmonary illness - The Impact of COVID-19 on Nephrology care.Patel D, Truong T, Shah N, Colbert GB, Thomas B, Velez JCQ, Lerma EV, Hiremath S.Dis Mon. 2020 Sep;66(9):101057. doi: 10.1016/j.disamonth.2020.101057. Epub 2020 Jul 25.PMID: 32758363 Free PMC article. Review.44.Rhabdomyolysis.Cabral BMI, Edding SN, Portocarrero JP, Lerma EV.Dis Mon. 2020 Aug;66(8):101015. doi: 10.1016/j.disamonth.2020.101015. Epub 2020 Jun 10.PMID: 32532456 Review.45.Patiromer for the treatment of hyperkalemia.Colbert GB, Patel D, Lerma EV.Expert Rev Clin Pharmacol. 2020 Jun;13(6):563-570. doi: 10.1080/17512433.2020.1774363. Epub 2020 Jun 8.PMID: 32511052 Review.46.The Clinical Relevance and Management of High-Flow Arteriovenous Access.Bucktowarsing B, Vin Y, Lerma EV.Adv Chronic Kidney Dis. 2020 May;27(3):214-218. doi: 10.1053/j.ackd.2020.03.001.PMID: 32891305 Review.47.Update and review of adult polycystic kidney disease.Colbert GB, Elrggal ME, Gaur L, Lerma EV.Dis Mon. 2020 May;66(5):100887. doi: 10.1016/j.disamonth.2019.100887. Epub 2019 Sep 30.PMID: 31582186 Review.48.Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and intensive care unit cases of SARS-CoV-2 (COVID-19) infection.McCullough PA, Eidt J, Rangaswami J, Lerma E, Tumlin J, Wheelan K, Katz N, Lepor NE, Vijay K, Soman S, Singh B, McCullough SP, McCullough HB, Palazzuoli A, Ruocco GM, Ronco C.Rev Cardiovasc Med. 2020 Mar 30;21(1):1-7. doi: 10.31083/j.rcm.2020.01.42.PMID: 3225989949.Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Clase CM, Carrero JJ, Ellison DH, Grams ME, Hemmelgarn BR, Jardine MJ, Kovesdy CP, Kline GA, Lindner G, Obrador GT, Palmer BF, Cheung M, Wheeler DC, Winkelmayer WC, Pecoits-Filho R; Conference Participants.Kidney Int. 2020 Jan;97(1):42-61. doi: 10.1016/j.kint.2019.09.018. Epub 2019 Oct 10.PMID: 3170661950.Autosomal dominant polycystic kidney disease: updated perspectives.Rastogi A, Ameen KM, Al-Baghdadi M, Shaffer K, Nobakht N, Kamgar M, Lerma EV.Ther Clin Risk Manag. 2019 Aug 26;15:1041-1052. doi: 10.2147/TCRM.S196244. eCollection 2019.PMID: 31692482 Free PMC article. Review.51.Kidney transplantation for the primary care provider.Ramaswamy K, Madariaga HM, Thomas BS, Lerma EV.Dis Mon. 2019 Aug 13:100869. doi: 10.1016/j.disamonth.2019.07.002. Online ahead of print.PMID: 3142008452.Class effects of SGLT2 inhibitors on cardiorenal outcomes.Kluger AY, Tecson KM, Lee AY, Lerma EV, Rangaswami J, Lepor NE, Cobble ME, McCullough PA.Cardiovasc Diabetol. 2019 Aug 5;18(1):99. doi: 10.1186/s12933-019-0903-4.PMID: 31382965 Free PMC article. Review.53.Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE, Mehrotra R, Stevens PE, Wang AY, Cheung M, Wheeler DC, Winkelmayer WC, Pollock CA; Conference Participants.Kidney Int. 2019 Jul;96(1):37-47. doi: 10.1016/j.kint.2019.01.017. Epub 2019 Apr 13.PMID: 3098783754.Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.Spinowitz BS, Fishbane S, Pergola PE, Roger SD, Lerma EV, Butler J, von Haehling S, Adler SH, Zhao J, Singh B, Lavin PT, McCullough PA, Kosiborod M, Packham DK; ZS-005 Study Investigators.Clin J Am Soc Nephrol. 2019 Jun 7;14(6):798-809. doi: 10.2215/CJN.12651018. Epub 2019 May 20.PMID: 31110051 Free PMC article.55.Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.House AA, Wanner C, Sarnak MJ, Pia IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, deFilippi CR, Cleland JGF, Anker SD, Herzog CA, Cheung M, Wheeler DC, Winkelmayer WC, McCullough PA; Conference Participants.Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.PMID: 3105338756.Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE; Conference Participants.Kidney Int. 2019 May;95(5):1027-1036. doi: 10.1016/j.kint.2018.12.025.PMID: 3101047857.Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies.Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, Yaqub MS, Birdwell KA, Bennett W, Dalal P, Kapoor R, Lerma EV, Lerman M, McCormick N, Bangalore S, McCullough PA, Dadhania DM.Nephrol Dial Transplant. 2019 May 1;34(5):760-773. doi: 10.1093/ndt/gfz053.PMID: 30984976 Review.58.Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, Lerma EV, Mezue K, Molitch M, Mullens W, Ronco C, Tang WHW, McCullough PA; American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology.Circulation. 2019 Apr 16;139(16):e840-e878. doi: 10.1161/CIR.0000000000000664.PMID: 3085291359.Renal complications during pregnancy: In the hypertension spectrum.Calimag-Loyola APP, Lerma EV.Dis Mon. 2019 Feb;65(2):25-44. doi: 10.1016/j.disamonth.2018.03.001. Epub 2018 Jun 8.PMID: 29891230 Review.60.Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.Roger SD, Spinowitz BS, Lerma EV, Singh B, Packham DK, Al-Shurbaji A, Kosiborod M.Am J Nephrol. 2019;50(6):473-480. doi: 10.1159/000504078. Epub 2019 Oct 28.PMID: 31658466 Free PMC article. Clinical Trial.61.Abdominal compartment syndrome.Sosa G, Gandham N, Landeras V, Calimag AP, Lerma E.Dis Mon. 2019 Jan;65(1):5-19. doi: 10.1016/j.disamonth.2018.04.003. Epub 2018 Nov 17.PMID: 30454823 Review. No abstract available.62.Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2.McCullough PA, Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Kluger SL, Rangaswami J.Rev Cardiovasc Med. 2018 Jun 30;19(2):51-63. doi: 10.31083/j.rcm.2018.02.021.PMID: 3103260363.Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review.Kluger AY, Tecson KM, Barbin CM, Lee AY, Lerma EV, Rosol ZP, Rangaswami J, Lepor NE, Cobble ME, McCullough PA.Rev Cardiovasc Med. 2018 Jun 30;19(2):41-49. doi: 10.31083/j.rcm.2018.02.907.PMID: 3103260264.Practice patterns in transitioning patients from chronic kidney disease to dialysis: a survey of United States nephrologists.Mallappallil MC, Fishbane S, Wanchoo R, Lerma E, Roche-Recinos A, Salifu M.BMC Nephrol. 2018 Jun 22;19(1):147. doi: 10.1186/s12882-018-0943-0.PMID: 29929485 Free PMC article.65.Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Eckardt KU, Bansal N, Coresh J, Evans M, Grams ME, Herzog CA, James MT, Heerspink HJL, Pollock CA, Stevens PE, Tamura MK, Tonelli MA, Wheeler DC, Winkelmayer WC, Cheung M, Hemmelgarn BR; Conference Participants.Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.PMID: 29656903 Free PMC article.66.Clinical hypertension: Blood pressure variability.Malik EZ, Abdulhadi B, Mezue KN, Lerma EV, Rangaswami J.Dis Mon. 2018 Jan;64(1):5-13. doi: 10.1016/j.disamonth.2017.08.003. Epub 2017 Sep 19.PMID: 28939280 Review. No abstract available.67.Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?Shah M, Gajanana D, Wheeler DS, Punjabi C, Maludum O, Mezue K, Lerma EV, Ardati A, Romero-Corral A, Witzke C, Rangaswami J.Cardiovasc Revasc Med. 2017 Jul-Aug;18(5):344-348. doi: 10.1016/j.carrev.2017.02.017. Epub 2017 Feb 28.PMID: 2828578668.The Evolution of the Journal Club: From Osler to Twitter.Topf JM, Sparks MA, Phelan PJ, Shah N, Lerma EV, Graham-Brown MPM, Madariaga H, Iannuzzella F, Rheault MN, Oates T, Jhaveri KD, Hiremath S.Am J Kidney Dis. 2017 Jun;69(6):827-836. doi: 10.1053/j.ajkd.2016.12.012. Epub 2017 Feb 21.PMID: 28233653 Review.69.Cardio-Renal Syndrome: A double edged sword.Naranjo M, Lerma EV, Rangaswami J.Dis Mon. 2017 Apr;63(4):92-100. doi: 10.1016/j.disamonth.2017.02.001. Epub 2017 Mar 14.PMID: 28302277 No abstract available.70.Nephroendocrinology: When endocrinology meets nephrology.Lerma EV, Koch CA.Rev Endocr Metab Disord. 2017 Mar;18(1):1-3. doi: 10.1007/s11154-017-9419-y.PMID: 28337588 No abstract available.71.Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.Perkovic V, Agarwal R, Fioretto P, Hemmelgarn BR, Levin A, Thomas MC, Wanner C, Kasiske BL, Wheeler DC, Groop PH; Conference Participants.Kidney Int. 2016 Dec;90(6):1175-1183. doi: 10.1016/j.kint.2016.09.010.PMID: 2788431272.Portal hypertension: Etiology, evaluation, and management.Tetangco EP, Silva RG, Lerma EV.Dis Mon. 2016 Dec;62(12):411-426. doi: 10.1016/j.disamonth.2016.08.001. Epub 2016 Oct 24.PMID: 27788916 Review. No abstract available.73.Two Cases of Acute Renal Infarction in the Setting of Atrial Fibrillation.Yousuf T, Ziffra J, Iqbal H, Said A, Oyama JH, Lerma EV, Chadaga AR.Ochsner J. 2016 Fall;16(3):312-4.PMID: 27660583 Free PMC article.74.Hepatorenal syndrome.Shah N, Silva RG, Kowalski A, Desai C, Lerma E.Dis Mon. 2016 Oct;62(10):364-375. doi: 10.1016/j.disamonth.2016.05.009. Epub 2016 Jun 29.PMID: 27372112 Review. No abstract available.75.Quantifying the Twitter Influence of Third Party Commercial Entities versus Healthcare Providers in Thirteen Medical Conferences from 2011 - 2013.Desai T, Dhingra V, Shariff A, Shariff A, Lerma E, Singla P, Kachare S, Syed Z, Minhas D, Madanick R, Fang X.PLoS One. 2016 Sep 26;11(9):e0162376. doi: 10.1371/journal.pone.0162376. eCollection 2016.PMID: 27668433 Free PMC article.76.Mineral metabolism in chronic kidney disease.Kochanek M, Said A, Lerma EV.Dis Mon. 2015 Oct;61(10):425-33. doi: 10.1016/j.disamonth.2015.08.003.PMID: 26518114 Review. No abstract available.77.Autosomal dominant polycystic kidney disease.Silverman J, Desai C, Lerma EV.Dis Mon. 2015 Oct;61(10):442-7. doi: 10.1016/j.disamonth.2015.08.005. Epub 2015 Sep 11.PMID: 26364947 Review. No abstract available.78.Anemia of chronic kidney disease.Kutuby F, Wang S, Desai C, Lerma EV.Dis Mon. 2015 Oct;61(10):421-4. doi: 10.1016/j.disamonth.2015.08.002. Epub 2015 Sep 11.PMID: 26364946 Review. No abstract available.79.Nephrolithiasis for the primary care physician.Tan JA, Lerma EV.Dis Mon. 2015 Oct;61(10):434-41. doi: 10.1016/j.disamonth.2015.08.004. Epub 2015 Sep 9.PMID: 26362879 Review. No abstract available.80.Renal LECT2 amyloidosis: a newly described disorder gaining greater recognition.Kowalski A, Cabrera J, Nasr S, Lerma E.Clin Nephrol. 2015 Oct;84(4):236-40. doi: 10.5414/CN108549.PMID: 26308079 Review.81.Twitter-Based Journal Clubs: Additional Facts and Clarifications.Topf JM, Sparks MA, Iannuzzella F, Lerma E, Oates T, Phelan PJ, Hiremath S.J Med Internet Res. 2015 Sep 16;17(9):e216. doi: 10.2196/jmir.4639.PMID: 26376668 Free PMC article. No abstract available.82.Chronic kidney disease.Said A, Desai C, Lerma EV.Dis Mon. 2015 Sep;61(9):374-7. doi: 10.1016/j.disamonth.2015.08.001. Epub 2015 Sep 2.PMID: 26342715 Review. No abstract available.83.Cardiovascular disease and chronic kidney disease.Gargiulo R, Suhail F, Lerma EV.Dis Mon. 2015 Sep;61(9):403-13. doi: 10.1016/j.disamonth.2015.07.005. Epub 2015 Aug 29.PMID: 26328516 Review. No abstract available.84.Hypertension and chronic kidney disease.Gargiulo R, Suhail F, Lerma EV.Dis Mon. 2015 Sep;61(9):387-95. doi: 10.1016/j.disamonth.2015.07.003. Epub 2015 Aug 29.PMID: 26328515 Review. No abstract available.85.Diabetes and chronic kidney disease.Kowalski A, Krikorian A, Lerma EV.Dis Mon. 2015 Sep;61(9):378-86. doi: 10.1016/j.disamonth.2015.07.002. Epub 2015 Aug 28.PMID: 26318277 Review. No abstract available.86.Dyslipidemia in chronic kidney disease.Kowalski A, Krikorian A, Lerma EV.Dis Mon. 2015 Sep;61(9):396-402. doi: 10.1016/j.disamonth.2015.07.004. Epub 2015 Aug 24.PMID: 26315102 Review. No abstract available.87.NephMadness 2015: nephrology as a cornerstone of medicine.Sparks MA, Lerma EV, Kupin W, Phelan PJ, Jhaveri KD, Topf J.Am J Kidney Dis. 2015 Mar;65(3):375-7. doi: 10.1053/j.ajkd.2014.12.002.PMID: 25704043 No abstract available.88.Urinary tract infections.Kumar S, Dave A, Wolf B, Lerma EV.Dis Mon. 2015 Feb;61(2):45-59. doi: 10.1016/j.disamonth.2014.12.002.PMID: 25732782 Review. No abstract available.89.Parameters used to discontinue dialysis in acute kidney injury recovery: a survey of United States nephrologists.Mallappallil MC, Mehta R, Yoshiuchi E, Briefel G, Lerma E, Salifu M.Nephron. 2015;130(1):41-7. doi: 10.1159/000381924. Epub 2015 May 19.PMID: 2599906390.Improving care coordination between nephrology and primary care: a quality improvement initiative using the renal physicians association toolkit.Haley WE, Beckrich AL, Sayre J, McNeil R, Fumo P, Rao VM, Lerma EV.Am J Kidney Dis. 2015 Jan;65(1):67-79. doi: 10.1053/j.ajkd.2014.06.031. Epub 2014 Aug 30.PMID: 2518338091.Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, Roger SD, Yang A, Lerma E, Singh B.JAMA. 2014 Dec 3;312(21):2223-33. doi: 10.1001/jama.2014.15688.PMID: 25402495 Clinical Trial.92.Multiple myeloma.Mehta GR, Suhail F, Haddad RY, Zalzaleh G, Lerma EV.Dis Mon. 2014 Oct;60(10):483-8. doi: 10.1016/j.disamonth.2014.08.002. Epub 2014 Oct 3.PMID: 25288376 Review. No abstract available.93.Sickle cell nephropathy.Gargiulo R, Pandya M, Seba A, Haddad RY, Lerma EV.Dis Mon. 2014 Oct;60(10):494-9. doi: 10.1016/j.disamonth.2014.08.004. Epub 2014 Oct 3.PMID: 25282510 Review. No abstract available.94.Renal amyloidosis.Jazbeh S, Said A, Haddad RY, Hamad A, Lerma EV.Dis Mon. 2014 Oct;60(10):489-93. doi: 10.1016/j.disamonth.2014.08.003. Epub 2014 Oct 1.PMID: 25280992 Review. No abstract available.95.Thrombotic thrombocytopenic purpura.Said A, Haddad RY, Stein R, Lerma EV.Dis Mon. 2014 Oct;60(10):500-4. doi: 10.1016/j.disamonth.2014.08.005. Epub 2014 Sep 30.PMID: 25278278 Review. No abstract available.96.Diabetic nephropathy for the primary care provider: new understandings on early detection and treatment.Kowalski A, Krikorian A, Lerma EV.Ochsner J. 2014 Fall;14(3):369-79.PMID: 25249803 Free PMC article. Review.97.Lipid, blood pressure and kidney update 2013.Banach M, Serban C, Aronow WS, Rysz J, Dragan S, Lerma EV, Apetrii M, Covic A.Int Urol Nephrol. 2014 May;46(5):947-61. doi: 10.1007/s11255-014-0657-6. Epub 2014 Feb 27.PMID: 24573394 Free PMC article. Review.98.The changing demographics of the global population predict that the number of people age 65 years or greater will triple over the coming decades. Introduction.Lerma EV, Rosner MH.Clin Geriatr Med. 2013 Aug;29(3):ix-x. doi: 10.1016/j.cger.2013.06.001.PMID: 23849017 No abstract available.99.Gastrointestinal and renal excretion of potassium in African-Americans and White Americans.Rosa RM, De Jesus E, Sperling K, Suh A, Gmurczyk A, Myrie KA, Rosner K, Lerma E, Yu W, Breuer R, Young JB.J Hypertens. 2012 Dec;30(12):2373-7. doi: 10.1097/HJH.0b013e32835a27b3.PMID: 23111624100.Statin treatment in patients with elevated liver enzymes: pitch to proceed.Berkelhammer C, Lerma EV.J Clin Lipidol. 2012 Jul-Aug;6(4):310-1. doi: 10.1016/j.jacl.2012.05.001. Epub 2012 May 22.PMID: 22836066 No abstract available.101.Hydrochlorothiazide versus calcium channel blockers: what is the best add-on to a renin-angiotensin system blocker for treating hypertension in patients with renal disease?Lerma EV.Curr Hypertens Rep. 2011 Oct;13(5):386-95. doi: 10.1007/s11906-011-0222-y.PMID: 21796332 Review.102.Are restless legs syndrome, pruritus or hiccoughs surrogates for inadequate dialysis?Lerma EV.Semin Dial. 2011 Jul-Aug;24(4):406-7. doi: 10.1111/j.1525-139X.2011.00888.x. Epub 2011 Jul 29.PMID: 21801207 No abstract available.103.Assessment and management of vascular disease risk in patients with chronic kidney disease.Brown WV, Bakris G, Lerma E, Chertow G.J Clin Lipidol. 2011 Jul-Aug;5(4):251-60. doi: 10.1016/j.jacl.2011.05.001. Epub 2011 May 23.PMID: 21784369 No abstract available.104.Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease.Ananthapanyasut W, Napan S, Rudolph EH, Harindhanavudhi T, Ayash H, Guglielmi KE, Lerma EV.Clin J Am Soc Nephrol. 2010 Feb;5(2):173-81. doi: 10.2215/CJN.03170509. Epub 2009 Dec 10.PMID: 20007681 Free PMC article.105.Anatomic and physiologic changes of the aging kidney.Lerma EV.Clin Geriatr Med. 2009 Aug;25(3):325-9. doi: 10.1016/j.cger.2009.06.007.PMID: 19765484 Review.106.Renal disease. Preface.Lerma EV.Clin Geriatr Med. 2009 Aug;25(3):xi-xiii. doi: 10.1016/j.cger.2009.07.009.PMID: 19765482 No abstract available.107.Treatment options for end stage renal disease.Crawford PW, Lerma EV.Prim Care. 2008 Sep;35(3):407-32, v. doi: 10.1016/j.pop.2008.05.003.PMID: 18710662 Review.108.Kidney diseases and hypertension. Preface.Lerma EV.Prim Care. 2008 Sep;35(3):xi-xiii. doi: 10.1016/j.pop.2008.06.005.PMID: 18710661 No abstract available.109.Approach to the patient with renal disease.Lerma EV.Prim Care. 2008 Jun;35(2):183-94, v. doi: 10.1016/j.pop.2008.02.001.PMID: 18486712110.Kidney diseases and hypertension, Part I. Preface.Lerma EV.Prim Care. 2008 Jun;35(2):ix-xi. doi: 10.1016/j.pop.2008.03.001.PMID: 18486711 No abstract available.111.Racial differences in potassium disposal.Suh A, DeJesus E, Rosner K, Lerma E, Yu W, Young JB, Rosa RM.Kidney Int. 2004 Sep;66(3):1076-81. doi: 10.1111/j.1523-1755.2004.00857.x.PMID: 15327401 Clinical Trial.112.Pasteurella multocida peritonitis: another risk of animal-assisted therapy.Sillery J, Hargreaves J, Marin P, Lerma E, Kuznia C, Abbe C.Infect Control Hosp Epidemiol. 2004 Jan;25(1):5-6. doi: 10.1086/503486.PMID: 14756211 No abstract available.

Favorite Place to Vacation

• HawaiiPhilippines

Dr. Edgar V. Lerma, MD's Practice location